Cargando…
Evolving landscape in the management of transthyretin amyloidosis
Transthyretin (TTR) amyloidosis (ATTR amyloidosis) is a multisystemic, multigenotypic disease resulting from deposition of insoluble ATTR amyloid fibrils in various organs and tissues. Although considered rare, the prevalence of this serious disease is likely underestimated because symptoms can be n...
Autores principales: | Hawkins, Philip N., Ando, Yukio, Dispenzeri, Angela, Gonzalez-Duarte, Alejandra, Adams, David, Suhr, Ole B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720049/ https://www.ncbi.nlm.nih.gov/pubmed/26611723 http://dx.doi.org/10.3109/07853890.2015.1068949 |
Ejemplares similares
-
Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014) -
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis
por: Obici, Laura, et al.
Publicado: (2016) -
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management
por: Palma, Jose-Alberto, et al.
Publicado: (2019) -
A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
por: Gonzalez-Duarte, Alejandra, et al.
Publicado: (2021) -
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)